News

Investor News from Reuters

December 09, 2015 - REUTERS

Delcath Prior Phase 3 Trial Results Published In Annals Of Surgical Oncology

December 08, 2015 - REUTERS

Delcath Announces CHEMOSAT Review Accepted for Publication in Cardiovascular and Interventional Radiology

December 02, 2015 - REUTERS

Delcath Announces CHEMOSAT Treatment Milestones In Europe

November 11, 2015 - REUTERS

Delcath Systems To Host Business Update Conference Call On November 17, 2015

November 10, 2015 - REUTERS

Delcath Reports 2015 Third Quarter Financial Results

November 02, 2015 - REUTERS

Data Supporting Delcath's CHEMOSAT System Presented At The European Association Of Dermato Oncology Annual Congress

October 15, 2015 - REUTERS

Delcath Announces First Patient Treated In ICC Cohort Of Global Phase 2 HCC Trial Program

October 14, 2015 - REUTERS

Delcath Phase 3 Trial Results To Be Published In Annals Of Surgical Oncology

October 08, 2015 - REUTERS

Delcath Announces National Reimbursement Coverage For CHEMOSAT Procedures In Germany

October 06, 2015 - REUTERS

Delcath Systems Appoints CEO Jennifer Simpson To Board Of Directors

September 30, 2015 - REUTERS

Data Supporting Delcath's Chemosat System Presented At The Cardiovascular and Interventional Radiology Society Annual Meeting

September 28, 2015 - REUTERS

Retrospective Study Examining Delcath's CHEMOSAT And Isolated Hepatic Perfusion Presented At ECCO Annual Meeting

September 09, 2015 - REUTERS

Delcath Announces Acceptance Of Abstract For Presentation At RSNA Annual Meeting

September 02, 2015 - REUTERS

Delcath To Present At The 17th Annual Rodman & Renshaw Conference

August 05, 2015 - REUTERS

Delcath Reports 2015 Second Quarter Financial Results

August 04, 2015 - REUTERS

Delcath Announces Acceptance of Abstracts for Presentation at the European Association of Dermato Oncology Annual Congress

July 20, 2015 - REUTERS

Delcath Receives Orphan Drug Designation From FDA For Melphalan To Treat Cholangiocarcinoma

July 16, 2015 - REUTERS

Delcath Announces Pricing Of Public Offering

June 09, 2015 - REUTERS

Delcath Announces Acceptance Of Abstracts For Presentation At The Cardiovascular And Interventional Radiology Society Annual Meeting

June 05, 2015 - REUTERS

Delcath to Webcast Management's Presentation at Annual Meeting of Shareholders on June 10, 2015

May 29, 2015 - REUTERS

Positive Data With Delcath's CHEMOSAT Highlighted At ASCO 2015

May 27, 2015 - REUTERS

Delcath's European Key Opinion Leader Forum On CHEMOSAT Therapy Affirms Benefits To Liver Cancer Patients

May 26, 2015 - REUTERS

Delcath Names Dr. Jennifer Simpson President And CEO

May 21, 2015 - REUTERS

ICC Cohort Of Delcath's Global Phase 2 Trial Of Melphalan/HDS In Hepatocellular Carcinoma Now Open For Enrollment

May 06, 2015 - REUTERS

Delcath Reports 2015 First Quarter Financial Results

April 21, 2015 - REUTERS

Delcath Receives Approval To Expand Global Phase 2 HCC Program To Include Patients With Intrahepatic Cholangiocarcinoma

April 10, 2015 - REUTERS

Delcath to present at Needham & Company's 14th Annual Healthcare Conference

April 07, 2015 - REUTERS

Delcath Adds New U.S. Center To Global Phase 2 Hepatocellular Carcinoma Program

April 02, 2015 - REUTERS

Delcath Activates Prospective Registry In Europe

March 27, 2015 - REUTERS

Data Highlighting Delcath's Melphalan/HDS Presented At The Society Of Surgical Oncology Annual Meeting

March 10, 2015 - REUTERS

Delcath Reports 2014 Fourth Quarter And Full Year Financial Results

March 09, 2015 - REUTERS

Delcath Announces Melphalan/HDS Poster Presentation To Be Presented At The Society Of Surgical Oncology Annual Meeting

March 03, 2015 - REUTERS

Delcath Announces Submission Of Phase 3 Trial Results For Publication In A Leading Peer-Reviewed Medical Journal

March 02, 2015 - REUTERS

Delcath To Present At The 27th Annual Roth Conference

February 11, 2015 - REUTERS

Delcath Prices $2.8 Million Public Offering of Common Stock and Warrants

February 10, 2015 - REUTERS

Delcath Announces Proposed Public Offering Of Common Stock And Warrants

February 03, 2015 - REUTERS

DELCATH RECEIVES VALUE 4 REIMBUREMENT STATUS FOR CHEMOSAT IN GERMANY